Benzinga | Jan 7, 2022 01:02PM EST

NRx Pharma Chair, CEO To Present Co. Business Update At HC Wainwright BioConnect Conference Jan. 10, 2022 At 7 a.m. EST

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage, biopharmaceutical company, today announced its Chairman of the Board and Chief Executive Officer, Prof Jonathan Javitt, MD, MPH, will be presenting updates to the Company's business at the H.C. Wainwright BioConnect Virtual Conference.

Details of the presentation can be found below:

Date: Monday, January 10, 2022

Time: 7:00 AM EST

Link to Presentation: https://journey.ct.events/view/1464b340-bd79-4a96-ae16-572a470d569b